A new study reveals how Staphylococcus aureus bacteria adopt a different diet when colonizing the lungs, suggesting a new treatment strategy for these often dangerous staph infections.
Researchers from the NIH RECOVER Initiative have identified long COVID symptoms in kids and teens, which could ultimately lead to improved diagnoses and treatments for millions.
A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
Obstacles remain before the world reaches the point of eliminating AIDS, but new prevention technologies and outreach programs are reasons to be optimistic about the future.
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
Initial reports of the bivalent booster’s effectiveness have created confusion among the public. David Ho discusses his own results, the bottom line, and what to expect from COVID this winter.
Cases of COVID, influenza, and RSV are surging in children and adults, along with a slew of other infectious diseases that went under the radar during the first two years of the pandemic.
More than 90% of Americans have been immunized against polio, but the news is still unsettling and has many wondering if they’re at risk of becoming infected or even paralyzed.
Three infectious disease experts at Columbia University Irving Medical Center presented the latest updates on monkeypox at a briefing Aug. 16 for CUIMC faculty, staff, and students.
The monkeypox has recently been declared a public health emergency in the United States and experts have expressed concern that the virus could become endemic.
The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.